Angel Sánchez Rodríguez-rekin lankidetzan egindako argitalpenak (3)

2012

  1. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

    European Journal of Clinical Investigation, Vol. 42, Núm. 5, pp. 548-556

2010

  1. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

    BMC Medicine, Vol. 8

2009

  1. Effect of different antihypertensive treatments on Ras, MAPK and Akt activation in hypertension and diabetes

    Clinical Science, Vol. 116, Núm. 2, pp. 165-173